Adina-Flavia Cutina-Morgovan

Dr. Adina-Flavia Cutina-Morgovan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
VIVlad Ivan
Vlad Ivan
Roxana BuzasRoxana Buzas
Roxana Buzas
ACAdina-Flavia Cutina-Morgovan
Adina-Flavia Cutina-Morgovan
PCPaul Ciubotaru
Paul Ciubotaru
MAMelania Ardelean
Melania Ardelean
DLDaniel Lighezan
Daniel Lighezan
Study basis: As a byproduct of protein metabolism, serum uric acid is a controversial risk factor and is the focus of several recent studies in the field of cardiovascular disease. Whether serum uric acid is involved in the development of these pathologies alone or in conjunction with other factors is a matter of debate. Objective: The objective of this study is to assess the direct relationship between serum uric acid and the ejection fraction. Methods: A retrospective study of 303 patients with heart failure, classified according to the ESC guidelines, was conducted, and several parameters, along with the relationship between serum uric acid and ejection fraction, were characterized. Results: A direct relationship between the level of serum uric acid and the ejection fraction was established (p = 0.03); patients with higher uric acid had an increased risk of having a lower ejection fraction. Conclusions: Serum uric acid, even when asymptomatic, is linked with the level of the ejection fraction of the left ventricle.

31 January 2024 in Life
Verified
Journal Article
Open access
PDF file
VIVlad Sabin Ivan
Vlad Sabin Ivan
Daniel Florin LighezanDaniel Florin Lighezan
Daniel Florin Lighezan
MAMelania Veronica Ardelean
Melania Veronica Ardelean
NBNicoleta Balteș
Nicoleta Balteș
AFAlexandra Corina Faur
Alexandra Corina Faur
Roxana BuzasRoxana Buzas
Roxana Buzas
Background: Myocardial infarction is currently the leading cause of death worldwide, followed by malignant neoplasms. The presence of both within the same patient obviously increases the risk of death, as many coronary events are detected in patients diagnosed with cancer. Diagnosis of an occult digestive cancer in the acute phase of myocardial infarction is most frequently prompted by a hemorrhagic complication. Case summary: This case features an 81-year-old male patient diagnosed with acute myocardial infarction, treated with primary percutaneous intervention (PCI), who developed post-stenting hemorrhagic complications in the first 24 h due to the presence of two different concomitant malignant neoplasms. The outcome was favorable in the acute phase, even if de-escalation therapy was given immediately post-stenting, and intrastent residual thrombotic risk was high. Conclusions: The presence of bleeding complications in patients with acute myocardial infarction should mobilize resources in search of a neoplastic cause, especially a digestive one. However, other locations should be looked for, depending on the source of bleeding.